Korsana Biosciences KRSA
NASDAQ KRSA
$31.20 -0.80 (-2.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Korsana Biosciences (KRSA) Non Operating Income (2020 - 2025)

Updated

Korsana Biosciences' Non Operating Income came in at $30,000 for Q3 2025, down 92.6% from $405,000 a year earlier and down 97.8% from the prior quarter.

Analysis

Korsana Biosciences (KRSA) Non Operating Income (2020 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Korsana Biosciences reported Non Operating Income of $1.43 million, up 122.7% year-over-year; for FY2024, it was $571,000, up 59.5% from FY2023.

  • Non Operating Income carries a four-year compound annual growth rate of -0.7% (FY2020 to FY2024).
  • Going back by year, Non Operating Income was $358,000 in FY2023 (+21.8%), $294,000 in FY2022, -$16,000 in FY2021 and $588,000 in FY2020.
  • The five-year range for quarterly Non Operating Income is -$6,000 (Q2 2021) to $1.35 million (Q2 2025).
  • Year-over-year, Non Operating Income increased in 1 of the last seven quarters, with growth averaging 1.9%.
  • The fastest year-over-year change in Non Operating Income over five years came in Q3 2024 (growth of 278.5%), and the weakest in Q3 2025 (a decline of 92.6%).
  • Business Quant data shows KRSA's Non Operating Income at $1.35 million (Q2 2025), $28,000 (Q1 2025) and $28,000 (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Korsana Biosciences 16.89 Mn 2.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 30,000.00
Jun 30, 2025 1.35 Mn
Mar 31, 2025 28,000.00
Dec 31, 2024 28,000.00
Sep 30, 2024 405,000.00
Jun 30, 2024 62,000.00
Mar 31, 2024 76,000.00
Dec 31, 2023 101,000.00
Sep 30, 2023 107,000.00
Jun 30, 2023 62,000.00
Mar 31, 2023 88,000.00
Dec 31, 2022 132,000.00
Sep 30, 2022 111,000.00
Jun 30, 2022 45,000.00
Mar 31, 2022 6,000.00
Dec 31, 2021 -1,000.00
Sep 30, 2021 -5,000.00
Jun 30, 2021 -6,000.00
Mar 31, 2021 -4,000.00
Dec 31, 2020 -4,000.00
API Access

Korsana Biosciences Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=KRSA&period=max&api_key=YOUR_API_KEY